Global Epilepsy Market Size to grow USD 4.7 Billion by 2030 | CAGR of 8.35%: Spherical Insights

According to a research report published by SphericalInsights, the Global Epilepsy Market Size was valued at USD 2.61 billion in 2021 and expected to reach USD 4.70 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 8.35% during the forecast period. Major vendors in the Global Epilepsy Market include LivaNova PLC, GlaxoSmithKline plc., Eisai Co., Ltd., Pfizer Inc., Medtronic, UCB S.A., NeuroPace, Inc., GW Pharmaceuticals plc., Novartis AG, Abbott, Teva Pharmaceutical Industries Ltd, Sunovion Pharmaceuticals Inc., Sumitomo Dainippon Pharma Co. Ltd., Bausch & Lomb Incorporated, Sanofi, Takeda Pharmaceutical Company Limited.,

Read the full article here.